Related Experiment Video
Updated: Jul 21, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever
Abstract:
Familial Mediterranean fever and inflammatory bowel disease are two inflammatory conditions. We showed that inflammatory bowel disease was particularly frequent and severe in non-Ashkenazi Jewish patients with familial Mediterranean fever.
Insights
Familial Mediterranean fever (FMF) is an inflammatory condition. Studies show FMF patients, particularly those of non-Ashkenazi Jewish descent, have a higher frequency and severity of inflammatory bowel disease (IBD).
Area of Science:
- Genetics and Immunology
- Gastroenterology
Background:
- Familial Mediterranean fever (FMF) and inflammatory bowel disease (IBD) are distinct autoinflammatory and chronic inflammatory conditions, respectively.
- Previous research suggests a potential link between FMF and IBD, but specific patient populations and disease severity require further investigation.
Discussion:
- This study highlights a significant association between FMF and IBD, particularly in non-Ashkenazi Jewish individuals.
- The findings suggest that FMF may exacerbate the frequency and severity of IBD in this specific demographic.
- Understanding this comorbidity is crucial for accurate diagnosis and effective management strategies.
Key Insights:
- Inflammatory bowel disease (IBD) occurs with notable frequency and increased severity in patients diagnosed with familial Mediterranean fever (FMF).
- The association is particularly pronounced in individuals of non-Ashkenazi Jewish heritage.
- This suggests a potential shared genetic or inflammatory pathway influencing both conditions in this population.
Outlook:
- Further research is warranted to elucidate the underlying mechanisms connecting FMF and IBD in non-Ashkenazi Jewish populations.
- Investigating targeted therapies for IBD in FMF patients could improve clinical outcomes.
- Longitudinal studies are needed to track disease progression and response to treatment.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

